Prise en charge du syndrome de relargage cytokinique et du syndrome d’activation macrophagique après traitement par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)-Reference-Cited by-同舟云学术

Prise en charge du syndrome de relargage cytokinique et du syndrome d’activation macrophagique après traitement par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Published:2021-12 Issue: Volume: Page:
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Tudesq Jean-Jacques,Yakoub-Agha Mathilde,Bay Jacques-Olivier,Courbon Corinne,Paul Franciane,Picard Muriel,Pochon Cécile,Sterin Arthur,Vicente Céline,Canet Emmanuel,Yakoub-Agha Ibrahim,Moreau Anne-Sophie^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference31 articles.

1. Beginning the CAR-T cell therapy revolution in the US and EU;Grupp;Curr Res Transl Med,2018

2. Chimeric antigen receptor T cell therapy for ALL;Maude;ASH Education Program Book,2014

3. Chimeric antigen receptor T cells in refractory B cell lymphomas;Schuster;N Engl J Med,2017

4. Real world experience of approved chimeric antigen receptor T cell therapies outside of clinical trials;Yassine;Curr Res Transl Med,2020

5. Clinical data, limitations and perspectives on chimeric antigen receptor T cell therapy in multiple myeloma;Beauvais;Curr Opin Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort;Annals of Intensive Care;2024-01-31

2. Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice;CA: A Cancer Journal for Clinicians;2023-01-10